Glioblastoma Multiforme

Showing NaN - NaN of 20

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Glioblastoma Multiforme Trial in Australia, United States (Nativis Voyager RFE Therapy)

Completed
  • Glioblastoma Multiforme
  • Nativis Voyager RFE Therapy
  • Birmingham, Alabama
  • +12 more
Jan 31, 2023

Glioblastoma Multiforme, Anaplastic Astrocytoma, Gliosarcoma Trial in Birmingham (M032, Pembrolizumab)

Recruiting
  • Glioblastoma Multiforme
  • +2 more
  • Birmingham, Alabama
    University of Alabama at Birmingham
Jan 30, 2023

Glioblastoma Multiforme Trial in United States (TPI 287, Bevacizumab)

Suspended
  • Glioblastoma Multiforme
  • Birmingham, Alabama
  • +8 more
Jul 19, 2022

Tumors, High Grade Glioma, Glioblastoma Multiforme Trial in Birmingham (Biological G207)

Not yet recruiting
  • Neoplasms
  • +7 more
  • Biological G207
  • Birmingham, Alabama
    Children's of Alabama
Jun 1, 2022

Glioblastoma Multiforme, Glioblastoma, GBM Trial in Worldwide (Dendritic cell immunotherapy)

Active, not recruiting
  • Glioblastoma Multiforme
  • +6 more
  • Dendritic cell immunotherapy
  • Birmingham, Alabama
  • +85 more
May 12, 2022

Glioblastoma Multiforme Trial in Canada, United States (drug, radiation, device)

Recruiting
  • Glioblastoma Multiforme
  • Birmingham, Alabama
  • +17 more
Apr 1, 2022

Glioblastoma Multiforme Trial in Worldwide (drug, other, radiation)

Terminated
  • Glioblastoma Multiforme
  • Steroid eye drops
  • +6 more
  • Los Angeles, California
  • +21 more
Mar 19, 2021

Glioblastoma Multiforme, Anaplastic Astrocytoma, Oligoastrocytoma, Mixed Trial in United States (Interferon-beta)

Completed
  • Glioblastoma Multiforme
  • +3 more
  • Interferon-beta
  • Birmingham, Alabama
  • +4 more
Nov 13, 2020

Glioblastoma Multiforme Trial in United States (poly ICLC, temozolomide, radiation therapy)

Completed
  • Glioblastoma Multiforme
  • poly ICLC
  • +2 more
  • Birmingham, Alabama
  • +8 more
May 30, 2019

Glioblastoma Multiforme Trial in United States (Cilengitide 500 mg, Cilengitide 2000 mg)

Completed
  • Glioblastoma Multiforme
  • Cilengitide 500 mg
  • Cilengitide 2000 mg
  • Birmingham, Alabama
  • +16 more
Jan 18, 2019

Glioblastoma Multiforme Trial in Austria, Canada, United States (ICT-107, Placebo)

Suspended
  • Glioblastoma Multiforme
  • ICT-107
  • Placebo
  • Birmingham, Alabama
  • +64 more
Aug 9, 2018

Glioblastoma Multiforme Trial in United States (ICT-121 DC vaccine)

Completed
  • Glioblastoma Multiforme
  • ICT-121 DC vaccine
  • Birmingham, Alabama
  • +5 more
Aug 9, 2018

Glioblastoma Multiforme Trial in United States (TPI 287, Bevacizumab)

Terminated
  • Glioblastoma Multiforme
  • Birmingham, Alabama
  • +10 more
Jan 30, 2018

Adult Brain Glioblastoma, Glioblastoma Multiforme Trial in United States (SL-701; poly-ICLC (polyinosinic-polycytidylic acid

Completed
  • Adult Brain Glioblastoma
  • Glioblastoma Multiforme
  • SL-701; poly-ICLC (polyinosinic-polycytidylic acid stabilized with polylysine and carboxymethyl cellulose)
  • Bevacizumab
  • Birmingham, Alabama
  • +15 more
Jan 24, 2018

Glioblastoma Multiforme Trial in Worldwide (NovoTTF-100A device, Temozolomide)

Completed
  • Glioblastoma Multiforme
  • Birmingham, Alabama
  • +88 more
Apr 7, 2017

Mixed Gliomas, Malignant Gliomas, Glioblastoma Multiforme Trial in United States (XL765 (SAR245409), Temozolomide)

Completed
  • Mixed Gliomas
  • +2 more
  • Birmingham, Alabama
  • +5 more
Apr 9, 2013

Malignant Glioma, Glioblastoma Multiforme, GBM Trial in United States (TM-601)

Unknown status
  • Malignant Glioma
  • +4 more
  • Birmingham, Alabama
  • +6 more
Jul 16, 2009

Malignant Glioma, Glioblastoma Multiforme, GBM Trial in United States (131-I-TM-601, 131I-TM601)

Unknown status
  • Malignant Glioma
  • +5 more
  • Birmingham, Alabama
  • +18 more
Apr 1, 2009